Related Experiment Video

Updated: Aug 5, 2026

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

Gordon syndrome and succinylcholine

A Puura1, R Schultz

  • 1District Hospital of Valkeakoski, Medical Center Mehiläinen, Tampere, Finland. puura@netti.fi

Journal of Inherited Metabolic Disease
|January 26, 2006
PubMed

Insights

A 6-year-old boy experienced severe hyperkalemia and ventricular tachycardia after succinylcholine. Early diagnosis and treatment of Gordon syndrome prevented further complications.

Area of Science:

  • Pediatric Anesthesiology
  • Clinical Genetics
  • Cardiology

Background:

  • Succinylcholine is a common muscle relaxant used in pediatric anesthesia.
  • Gordon syndrome is a rare genetic disorder characterized by hyperkalemia and hypertension.
  • Metabolic disorders can increase risks associated with anesthetic agents.

Observation:

  • A 6-year-old boy developed severe hyperkalemia and ventricular tachycardia post-succinylcholine administration.
  • The patient's cardiac rhythm was successfully managed with defibrillation.
  • Subsequent diagnosis revealed Gordon syndrome.

Findings:

  • Gordon syndrome predisposes pediatric patients to life-threatening hyperkalemia following succinylcholine use.
  • Succinylcholine can trigger severe hyperkalemic cardiac events in susceptible individuals.
  • Prompt diagnosis and management of Gordon syndrome are crucial.

Implications:

  • Anesthesiologists should consider underlying metabolic disorders like Gordon syndrome in pediatric patients.
  • Screening for genetic conditions may be warranted in cases of unexplained hyperkalemia post-anesthesia.
  • This case highlights the critical need for awareness of succinylcholine risks in children with specific genetic predispositions.

More Related Videos

Measuring Neuromuscular Junction Functionality10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

Retrograde Neuroanatomical Tracing of Phrenic Motor Neurons in Mice09:05

Retrograde Neuroanatomical Tracing of Phrenic Motor Neurons in Mice

Published on: February 22, 2018

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...